Looking for lessons in cancer's 'miracle' responders
Nearly every oncologist can tell the story of cancer patients who beat the odds, responding so well to treatment that they continued to live many years disease-free, while most of their peers worsened and eventually died.
Join the discussion below, or Read more at Fox News.
Since: Dec 05
#1 Sep 16, 2013
I read the article and shake my head, what of these outliers? Some private laboratory oncologists have been saying for years, what of those complicated disease entities like cancer, whose complexity and variability challenge even the best of minds? How do we bang the round peg of cancer therapy into the square hole of formulaic care?
For years, they've been used to standardized guidelines that provide the same treatment to every patient with a given diagnosis. Virtually every medical oncologist knows the drill. The result: the average patient has an average outcome with the average treatment. By encompassing regimens into standardized algorithms, they may soon be able to eliminate themselves entirely, with supercomputers.
While clinical trials are designed to identify average improvements for average patients, virtually every trial conducted has patients who live much longer than average. They constitute the tail on the survival curve (the outliers) and almost every trial has several. The job of medical oncologists is to identify those true responders and treat them appropriately.
One of those laboratory oncologists told me one time that the term applied for these failures in the average patient paradigm are "beta errors," meaning that the investigators missed the benefit of a given treatment. By identifying active treatments in small subsets of patients, phenotype analytic tools can enable them to select those small subsets for treatment regardless of average expectations.
Add your comments below
|Myriad Genetics Announces an Assay that Identif...||Nov 24||Purplemouse2||2|
|gREEN tRees Purp haze, Afghani, SOur Diesel nOW...||Oct '16||D_Drank||1|
|Genetic hallmarks of acute lymphoblastic leukem...||Oct '16||Stephany McDowell||1|
|MALAT1 is a driver for metastasis||Oct '16||Kirkits||1|
|Yale Expert Speaks on Metastatic Breast Cancer ...||Oct '16||Stephany McDowell||1|
|Breast cancer diagnosis: When to seek a second ...||Oct '16||Javk||1|
|Identical Twins Diagnosed With Same Rare Cancer...||Sep '16||Stephany McDowell||1|
Find what you want!
Search Oncology Forum Now
Copyright © 2016 Topix LLC